位置:首页 > 蛋白库 > GRA1_GIBZE
GRA1_GIBZE
ID   GRA1_GIBZE              Reviewed;        7839 AA.
AC   A0A098D1P1; A0A0E0RKU6;
DT   12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT   07-JAN-2015, sequence version 1.
DT   23-FEB-2022, entry version 43.
DE   RecName: Full=Nonribosomal peptide synthetase GRA1 {ECO:0000303|PubMed:30395461};
DE            EC=6.3.2.- {ECO:0000269|PubMed:30395461};
DE   AltName: Full=Gramillins biosynthetic cluster protein 1 {ECO:0000303|PubMed:30395461};
DE   AltName: Full=Nonribosomal peptide synthetase 8 {ECO:0000303|PubMed:26693688};
DE            Short=NRPS8 {ECO:0000303|PubMed:26693688};
GN   Name=GRA1 {ECO:0000303|PubMed:30395461}; Synonyms=NRPS8;
GN   ORFNames=FG00042, FGRAMPH1_01T00143, FGSG_15673;
OS   Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084
OS   / PH-1) (Wheat head blight fungus) (Fusarium graminearum).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Nectriaceae; Fusarium.
OX   NCBI_TaxID=229533;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1;
RX   PubMed=17823352; DOI=10.1126/science.1143708;
RA   Cuomo C.A., Gueldener U., Xu J.-R., Trail F., Turgeon B.G., Di Pietro A.,
RA   Walton J.D., Ma L.-J., Baker S.E., Rep M., Adam G., Antoniw J., Baldwin T.,
RA   Calvo S.E., Chang Y.-L., DeCaprio D., Gale L.R., Gnerre S., Goswami R.S.,
RA   Hammond-Kosack K., Harris L.J., Hilburn K., Kennell J.C., Kroken S.,
RA   Magnuson J.K., Mannhaupt G., Mauceli E.W., Mewes H.-W., Mitterbauer R.,
RA   Muehlbauer G., Muensterkoetter M., Nelson D., O'Donnell K., Ouellet T.,
RA   Qi W., Quesneville H., Roncero M.I.G., Seong K.-Y., Tetko I.V., Urban M.,
RA   Waalwijk C., Ward T.J., Yao J., Birren B.W., Kistler H.C.;
RT   "The Fusarium graminearum genome reveals a link between localized
RT   polymorphism and pathogen specialization.";
RL   Science 317:1400-1402(2007).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1;
RX   PubMed=20237561; DOI=10.1038/nature08850;
RA   Ma L.-J., van der Does H.C., Borkovich K.A., Coleman J.J., Daboussi M.-J.,
RA   Di Pietro A., Dufresne M., Freitag M., Grabherr M., Henrissat B.,
RA   Houterman P.M., Kang S., Shim W.-B., Woloshuk C., Xie X., Xu J.-R.,
RA   Antoniw J., Baker S.E., Bluhm B.H., Breakspear A., Brown D.W.,
RA   Butchko R.A.E., Chapman S., Coulson R., Coutinho P.M., Danchin E.G.J.,
RA   Diener A., Gale L.R., Gardiner D.M., Goff S., Hammond-Kosack K.E.,
RA   Hilburn K., Hua-Van A., Jonkers W., Kazan K., Kodira C.D., Koehrsen M.,
RA   Kumar L., Lee Y.-H., Li L., Manners J.M., Miranda-Saavedra D.,
RA   Mukherjee M., Park G., Park J., Park S.-Y., Proctor R.H., Regev A.,
RA   Ruiz-Roldan M.C., Sain D., Sakthikumar S., Sykes S., Schwartz D.C.,
RA   Turgeon B.G., Wapinski I., Yoder O., Young S., Zeng Q., Zhou S.,
RA   Galagan J., Cuomo C.A., Kistler H.C., Rep M.;
RT   "Comparative genomics reveals mobile pathogenicity chromosomes in
RT   Fusarium.";
RL   Nature 464:367-373(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1;
RX   PubMed=26198851; DOI=10.1186/s12864-015-1756-1;
RA   King R., Urban M., Hammond-Kosack M.C.U., Hassani-Pak K.,
RA   Hammond-Kosack K.E.;
RT   "The completed genome sequence of the pathogenic ascomycete fungus Fusarium
RT   graminearum.";
RL   BMC Genomics 16:544-544(2015).
RN   [4]
RP   INDUCTION.
RX   PubMed=26693688; DOI=10.1016/j.funbio.2015.10.010;
RA   Harris L.J., Balcerzak M., Johnston A., Schneiderman D., Ouellet T.;
RT   "Host-preferential Fusarium graminearum gene expression during infection of
RT   wheat, barley, and maize.";
RL   Fungal Biol. 120:111-123(2016).
RN   [5]
RP   FUNCTION, DISRUPTION PHENOTYPE, INDUCTION, AND PATHWAY.
RX   PubMed=30395461; DOI=10.1021/jacs.8b10017;
RA   Bahadoor A., Brauer E.K., Bosnich W., Schneiderman D., Johnston A.,
RA   Aubin Y., Blackwell B., Melanson J.E., Harris L.J.;
RT   "Gramillin A and B: cyclic lipopeptides identified as the nonribosomal
RT   biosynthetic products of Fusarium graminearum.";
RL   J. Am. Chem. Soc. 140:16783-16791(2018).
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene cluster
CC       that mediates the biosynthesis of gramillins A and B, bicyclic
CC       lipopeptides that induce cell death in maize leaves but not in wheat
CC       leaves (PubMed:30395461). The nonribosomal peptide synthetase GRA1
CC       incorporates respectively a glutamic adic (Glu), a leucine (Leu), a
CC       serine (Ser), a hydroxyglutamine (HOGln), a 2-amino decanoic acid, and
CC       2 cysteins (CysB and CysA) (Probable). The biosynthesis of 2-amino
CC       decanoic acid incorporated in gramillins could be initiated by a fatty
CC       acid synthase composed of the alpha and beta subunits FGSG_00036 and
CC       FGSG_11656 (Probable). The cytochrome P450 monooxygenase FGSG_15680
CC       could hydroxylate the fatty acid chain (Probable). Subsequent oxidation
CC       to the ketone by the oxidoreductase FGSG_00048 and transamination by
CC       aminotransferase FGSG_00049 could form 2-amino-decanoic acid
CC       (Probable). On the other hand, FGSG_15680 could also be responsible for
CC       the HO-modified glutamine at the gamma-position (Probable). Whether
CC       hydroxylation occurs on the fully assembled product or on the Gln
CC       residue prior to assembly into the gramillins requires further proof
CC       (Probable). The thioredoxin FGSG_00043 could also be required for the
CC       disulfide-bond formation between CysA and CysB (Probable). The specific
CC       involvement of the remaining proteins from the cluster is more
CC       difficult to discern, but could have broader regulatory (FGSG_00040 and
CC       FGSG_11657) or enzymatic functions (FGSG_00044 and FGSG_00045)
CC       (Probable). The final C-domain of GRA1 does not possess the expected
CC       sequence of a termination CT domain, often implicated in
CC       macrocyclization and release of a cyclopeptidein fungal NRPs; and the
CC       thioesterase FGSG_00047 may act in concert with the terminal C-domain
CC       of GRA1 to catalyze the formation of the macrocyclic anhydride and
CC       release of the products (Probable). {ECO:0000269|PubMed:30395461,
CC       ECO:0000305|PubMed:30395461}.
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:26693688}.
CC   -!- INDUCTION: Expressed during infection of maize kernels and exhibits
CC       transient expression during barley and wheat spike infection
CC       (PubMed:26693688). Coexpressed alongside the trichothecene biosynthesis
CC       gene cluster (PubMed:26693688). {ECO:0000269|PubMed:26693688}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. Occasionally,
CC       epimerase (E) domains (responsible for L- to D-amino acid conversion)
CC       are present within the NRP synthetase. GRA1 has the following
CC       architecture: A-T-C-A-T-C-A-T-C-A-T-C-A-T-C-A-T-C-A-T-C.
CC       {ECO:0000305|PubMed:30395461}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes the production of gramillins A and B.
CC       {ECO:0000269|PubMed:30395461}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HG970332; CEF71871.1; -; Genomic_DNA.
DR   SMR; A0A098D1P1; -.
DR   STRING; 5518.FGSG_11659P0; -.
DR   VEuPathDB; FungiDB:FGRAMPH1_01G00143; -.
DR   eggNOG; KOG1176; Eukaryota.
DR   eggNOG; KOG1178; Eukaryota.
DR   Proteomes; UP000070720; Chromosome 1.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   Gene3D; 1.10.1200.10; -; 7.
DR   Gene3D; 3.30.300.30; -; 7.
DR   Gene3D; 3.30.559.10; -; 8.
DR   Gene3D; 3.40.50.12780; -; 7.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   Pfam; PF00501; AMP-binding; 7.
DR   Pfam; PF00668; Condensation; 7.
DR   Pfam; PF00550; PP-binding; 7.
DR   SMART; SM00823; PKS_PP; 6.
DR   SUPFAM; SSF47336; SSF47336; 7.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 7.
DR   PROSITE; PS00455; AMP_BINDING; 6.
DR   PROSITE; PS50075; CARRIER; 7.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 2.
PE   2: Evidence at transcript level;
KW   Ligase; Phosphopantetheine; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..7839
FT                   /note="Nonribosomal peptide synthetase GRA1"
FT                   /id="PRO_0000450560"
FT   DOMAIN          793..866
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          1880..1957
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          2963..3040
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          4057..4134
FT                   /note="Carrier 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          5113..5189
FT                   /note="Carrier 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          6207..6282
FT                   /note="Carrier 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          7290..7366
FT                   /note="Carrier 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          264..650
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          916..1332
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          1351..1742
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          1997..2413
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          2432..2828
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          3084..3496
FT                   /note="Condensation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          3520..3923
FT                   /note="Adenylation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          4234..4569
FT                   /note="Condensation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          4591..4982
FT                   /note="Adenylation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          5224..5653
FT                   /note="Condensation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          5671..6069
FT                   /note="Adenylation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          6321..6730
FT                   /note="Condensation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          6756..7147
FT                   /note="Adenylation 7"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   REGION          7404..7704
FT                   /note="Condensation7"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:30395461"
FT   COMPBIAS        8..23
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         827
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1918
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3001
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         4095
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         5150
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         6243
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         7327
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   7839 AA;  863791 MW;  ACF11A5B8B677BF0 CRC64;
     MALLNGKSTL PNGHNSSIES PNGYTEHEMP IPSDWQRYLI DIDHAAVSLF KSPRPDDPVA
     TVKSTHRFVL TEETLLVSIP STIYAAFAIV MSEYSNSQDV LFGVRAESRV VPFRVLVDKN
     DQISSFLDQV ASKWKMAQNF PPDMPVPAVP NVLAFVDDKM SASGNGLVLE ENEEISMVIS
     LDSKEITIQV LFNPACADLV AVQRFLKQLE TVFHQLCKPS AGQLIKEVKS ITADDIRDMT
     TWNSASMTPY TPECIHDVVK QHVLASPNSC AVHGWDGDLS YVQLDEESSR LANYLYRKGV
     RPHDLVPLAF YKSIWFTICA LALSKLGAAI VPLDPQWPKD RQMYIINDIE SSRIITNIPN
     SASAYAGLEI IDISQLSLAN EPATARYPVT PEHAIYAYYT SGTTGQPKGC VIEHGAFVSS
     SSKRIKFMGR NKDSRLLQVT TYTFDVAMDD IFFTLMAGGC LCVPTREECL NDIVGAVEKY
     NCNTLHVAPS LARDLQPSQL PSLRTLILGG EAMSANILRT WAGRVGLYNS YGPTECCIAC
     CVNLIQSADE NPRNIGRPID CSYWLVRPGD IDTLAAIGTV GEILIHGPNL GRGYLNKPEL
     TAKAFPQNIS WASEVGLPAE ARFYRTGDLA RFNADGSVCL LGRIDDQVKI HGQRIELGEI
     DYRLSQCLPA GIEAISGVVN FRDREVATLV AFIQTVNSDS NSAKSSGSLA LADTDNWNQF
     HRLRSHVMEQ LSHNLPSYMV PSVFLPVQNF LYFNQGKLNR RGMFQQASRF RLDDILTINT
     SAGHKADDTS SWSAEALVLR QLWAIALGLE EKNIHLDSRF ADLGGDSLAA IRLGILCRPY
     DIELSVDDIL QQSTILLQAE MSEKKKKQNI EKHEVAQEAI LPAGQRFGLL GQDVDVGMLC
     EQTSAQCHID SGAIDDIYPA SPLQESLMAL SMDDSPYISQ FVFRLPDNLD MYRFRKAWKS
     TFSDIPILRT RIIYLQDFGT LQVVVDEDIE WTEHKNITLS QFLKDDQERL MQVGDRLVRF
     TIVQESPGTS FLVWTCHHAC HDGRTVDQTL RVVGAKYLDR PVSSPVPYRY YIQFQQDVYR
     RDWQEYWTRN LAGASVSAFP AQDKAVHQPV TDASHQYSFS MPRISTERSD TSVFSPSSIL
     RAAWALIVSR YEESEDVTFG TIVGANASTI ADADAIVGPT NNTIPVRVLA SEGWTVEAFV
     SHVKQQFEYS PFQHVGLANL KDLSPEMQDI VNIRNIFVVQ SHFVGQTGSE MNLERVAVSA
     HEGFKYPLVV ECFQENASQV LVNFIYDSHI LDQSQISRLA LQLENTINLL VHNPHKTLNQ
     IEILSPSDVA QILEWQADMP SPSSLCLHQQ FFTQVKRSPD AIALCTWEGQ FTYLEVQNLV
     ESMAIYLQDA GVRRGDRILC QIEKSACAVI SFLAILKLGG TCVLLGTTWP RIRSEVIAED
     TKAQYLLVSP TLSNALISLV PNILEVSTSF IQRLPRPTQY VDSVYQPSDL AFILFTSGST
     GTPKGVQLAH SGLVTNFASM AQHMQYTSET RLFQFSDFTF DLSIYDIFGM LMVGGCICMP
     SEQERHEDLM GSMNRMKVNT VTATPSIAKM IKPSSVPTLR CIKLGGEALD STTLATLAGS
     LDTENGYGVT ECSVWSTCTD RLSPDADPRN VGRGINCYTW IVDAKNPNRL RPIGAVGELI
     LQGPGVALGY VNKPEESKRV FLDALPWSTD KGRSYRTGDL VKYAPDGSLI YVQRKDAQLK
     IRGQRFESSE VESHLQQCGL PEGNFCVDLV KTQTGPVVVV FLCMNKEVEM KDASKLGVVP
     LDQQDSSIVD QMAQAMRMLI PRLPGYMIPQ AVIPVTQMPV SNSGKLDRRA LRSLADGMSP
     GQLRQLLRPS EDSIYHKRTE LETEAERTMA VLWSQVLAID DSHVFHTDDD FFQLGGHSIA
     LMRLISAGKG HGMSISYRDA FLHPSLGAMS RQATVSDAEE HALPRLIQPF AMAPSDVDGL
     IQESSRACQV DPQDIVDLYP CTPFQESTMT LSLSKPGLYT AQFVWSLPDT IDLARLRSAW
     ETLVRSDAIL RTRLIYSSKY WQVVTRTGID FALADMSIDS YLEEDKARPI RLGQPLNRLA
     IIQDQTSATQ YLAWTAHHST YDGHSWSSIQ DRLSDLYTQG GSKLPLVPYN VFVDHIVNNP
     LPETGLSFWK DMMSGARMPS FPKLPLNNDL QSTNSVVTQS VSLPRQTSSD VTVASAIQGA
     WAILLGQYEN SDDVLFAATL SGRNVPVDGI ENIAGPTSCT VPMRVRTDPG QSTRSWLRSV
     QQSYVDAATY GQIGMNEISL VNKDAEVARH IRSLLIVQAI TSKTVSGLER IGCTKIETKA
     KGFLSYALVV ECKPSMENNE MEVMVSYDAN LLDGPSVYRL VWQLEFTLQQ LLSDNCKTIR
     DLCLISPSDM ETISTWNKEL PKTVETTVHA LFDRRLSQKH SATAISSWDG EMTYVELDNY
     SSSLAAHLMA SGVKPGQYIP LCFEKTMWMV VSMLAVLKAG GACVSLDPNH PSRHHQVILS
     RVSADIVITS PANKHRFPGN RVLSVSAALM TKIAHEPYAA PLVSAHQPAF VVFTSGTTGE
     PKGIILEHRA LCTSIEAHGQ FMEFGPESRV LQFASYTFDV SIAEMLTTLA FGGCICIPSD
     HARLNNLSGA IKTLRVNQAY LTASVAALLD PDTLNGSLKV LSVGGEQVGQ EVLTRWGDRT
     KLLNMYGPAE TTIWCGGKHS VKPDGDAANI GYGVGARMWL TDVNDVQKLA PIGAVGEIVI
     EGPLLARGYI NGNNDVFVES PDWAKAFNVF DGFDQVTGRV YRSGDLGRYQ SDGSIAICGR
     RDTQLKIRGQ RVEVSQIEDQ LQRLAPDFKC VVGVLRTDTP TLVAFIGLEG PTKDQGLTDS
     MDLVVRTRDL SEEVRDLMGS LESRLANILP PYSVPAHYLV LRNIPLMTSG KTDRKKLQVI
     ASEHLEHSVD ASKPQMLQQV KKIPTTQMEW NLFGLWAQVL GINNLASLGT DDNFFRCGGD
     SLKAMQLASL ASQRGITLQV SDLFKNPVLA DLAQAIVLDT PKEIETSPVQ DIPDPYSLLP
     NDTKEQVQAQ AALDCDVSPN LIDDIYPCTP LQDGLFALSQ KQPGAYVAQF KFSVANRINI
     RRLRQAWETV CDQAPILRSR LVSTPSGIVQ VVLTEDFWWY ERHDIDTSAE LEQDKAAIGG
     LGQPLQRFRL VQDVARGQKT LVWTIHHAAF DGWSIERILE SVRLVYQDQP IPNPYVPFNA
     FIRYSSGIVE NHESKEFWQS YLSNITPPTF PALPSPSYQA LADTVIESKM SNLKLPDSFT
     LTSILRAAWA IVVSTYQGSD DVVFLTTVFG RNAPLAGIDK IIGPTITTIP IRVKLNDPST
     TVDMLLQAVQ ESATETMAFE QLGLQSIRNL NADCKAACMA QNLLVIQTSR GEDATVPFGG
     FEKLPDETKG FSTIPFTLEC TATSEGGLSI EASFDSKIVD PAQANRIIKT FEHVTQQMCH
     KHLKLNQVDL ISDSDHDLIR NWNSTMPCAK EECIHHRLDR LAVSNPDAEA VCAWDGIFTF
     KELNSLSNRY AVYLQSQGIK PGNIVPFCFD KSKWVVVAML AIMKVGAASV TVDPKHPPGR
     RDGILSAVSA SAVVTTSGYT HLFDHNASHG LKTLVLDGKT MDSIADSLQP ADIESTPNDA
     AFVVYTSGST GTPKAVVIEH RGICTGAFHL AKLIHLGPQT RCLQFAAFTF DQSFGDIFHT
     LLLGGCVCIP SESDRLNDLV GSILRLRANT AILTPTVACS IDPSELGSHK MDVLTVGGEP
     VTAEAIRTWA PHVRLFNTYG PAECSVTTIG RPINMQNVTQ PANIGRGLGA LVWLTYPDDP
     ERLTPIGTVG EILMEGPQLA RGYLNDSRNT NAAYITDPAW SHRFPVPGMS TPRRFYRTGD
     LGQYQADGTI VCLGRRDSQV KLRGQRMELG EVEHHISTYS QSALEIIADV FTPPNGTATL
     AACISLKGYE TKGDECQVEV DEQVLTIFSA MLSGLDSYLS RMLPAYMIPT LYVPVTHIPL
     TPSGKKDRKS IRLMLARITV DQVQKMRTIL GESEPSRPLT EREKDLQQLW VKVLKLDGET
     VINANTNFFH SGGDSVRAMA LVAAARRKGT HLTVAEIFSH PKLCDMAAMT TSLSQKGQPV
     QLAPYSLLRS TPSADTMSEA CGACGVDHSQ IQDMYPTTPL QQALVALSIK DSGAYVSNFV
     FLLPSHLDVE LFQRAWECVY VVVSEKVRWN YGDNLEEFVG RQSQKGFKLG QRMAESAIVR
     QKDGKTFFIL ILHHAIYDGW SLRRLLEAAE QIYHGQAIPR FVIFNHFVAH VSRSEDNRAP
     AFWRSYLEGL PKTSFIQQPT TAYKPTADHI ISQDVSLRDN FTARSGVTIT SLMRAAWAMV
     LATYNSDQTP DVVFGTVVGG RSLDLADIEY IDGPTIATVP FRVTFDPTAP VDMLLQSVQT
     MSTQILQHEQ FGVQNIIKVS DDGRLACDFE TLLVVQDSAE IKASSGFLDM DNIYQRPDRP
     PGIPLVVECS PSAGNLHLEI HFDAKLLEET QAKRLIRQLA HVIKQLANSV PSLSLSCIDM
     MNPDDAEEIK SWNKKPPPTF DGCLHEMVLQ HSKGCPDRIA IQSWDTSLTY SELDHLSSIL
     AQYLNSLGVR PEDKVPFCMD KSAFAIVAML AILRSGGCFV PLDMSSPTKR LKNIIKRVNA
     KFILVSPKTR PLFEDVEGQL VEVTKSMIDG LPELSKSLYI PSATHPAYVL FTSGSTGTPK
     GVVVEHGAIA TSVSSFSSYL GFNPDVRVLQ FAPYVFDVSI GEIFACLVSG GCLCIASESS
     LMDDLPLCIQ QLDVNFAVLT PTFARTLTPS EVPSLKTLVL GGEPLRKRDV ETWATTVRLF
     NGYGPTEASV LAMAYRVPDS QSPCNLIGLS VGCRSWIVSP SDPNILPPIG AVGELVLEGN
     TLARGYLDTE SAQGAFIEDP KFLDSLVPEA TGSRVYKTGD LVRYNAEGIV EFVSRKDTQV
     KFHGRRIELE DIEHNAMEAM PEAKHLVVEL VRLGNSQQEA LALFFHTDNQ RTANEKDPIL
     PIGQDLVARL RGVKSNLAVT LPSYMVPSLY IPLSTWPSTS NGKVNRHLLR NLVLHFTSEA
     AAAYSLHTGD SSALSSDEES QLAQLWATTL NIDARTIGSS DSFFQHGGDS IAAVRLVTLA
     REQGIGLSVD TLLSKPILRD MALCMTSAQP VRETIVRPFN QIHSHQEEVL LAASQFGVEP
     AMIEDIYPCS ALQNSLMAVS LKNSSAYLSQ FVVAIPEGLD IDVLQAAWNT VYSDSPILRT
     RFYQPSLNNM QHPILQAVVD QKPIWGTEEN LDEFLGRDKQ TPTGLGSPLT RFTIVVDKTN
     QERLFVLTAH HAIYDGWSIA STFEKVDMIL KGIALPKSVG YNIFIHHLQS LNTQENKAFW
     SSTLEGATQT LFPQLPSHSY EPATDNSLKH QFAYPADLAP HSTVTMATIV RGAWGLLVSK
     YCDSPDVVFG TTVNGRMAPI PGIEMVQGPT MATIPFRTRI STNQSVLSYL EQLHVQQIES
     IPHEQYGLQN IKHLSEPIAR VCEFQNLLVI QSSRDSSLSD SGFAFGTVKN MDQGSFSMQG
     FHNMALVVEC SIDSEVIHVT LNFDSNVIPK TQVQRIAHHF EHLILQLQAG STEPDLKIDQ
     IDHVSPSDQA EILEWNSSIP GSVLCCVHEL FESRARLQPS APAICARDGQ LTYFELQAKA
     TTLAAYLSLQ GLGRGVLVPL LFEKSCWAVV AMMAVLKAGA ANVALNPEHP QARLEDSINA
     TQGEVILCSR KHFELASSFD MQVIVVDEDL FHHIDLPSLA SSDPWSPTYP AGPDDPCFVL
     FTSGTTGKPK GIVINHAAMC SSINGHSSTL RYSTGPGSRN FQFTAYTSDV SIGEIFTSLA
     VGSCVCVPSD YDRMNNLAGS MRDLNVTWAF LTPSVAALLK PEEVPCLRTL LFGGETATPE
     NISTWADSLY LINSAGPAEC CIWTHCNPGI STADIGSNWG YNLGCATWIT DPNNPSVLMP
     IGVTGEMLIE GPNLAQGYLN DPERTQKSFV EIYLAGKKRR LYRTGDLARF MADGKTQFLG
     RRDTQVKLRG QRVEIGEIEN QIRRHIPDST LVAVEMVRIA EGKSAPLLAA FHAPKDPRAI
     DDTGDTPQAE VLSAAMVQEL GVILDELAAK LAETLPQHMI PTAFIPLTSM PLTASAKTDR
     NVLSALASTI SVEQLSYYAL TSAEKQFPSS LAEQQMAKLW QEVLNTKIDI GIHDSFFRIG
     GDSISAMHLV SRSRAVGISL TVEQIFKNPT LQHMAAIATT FTESMGSTTV EPFSLISPTV
     TFDIVCSEAQ EQCQVTAQQI QDIYPCSALQ EGLLALSLKT AGSYLAQMVF EIPDELDLER
     FKDAWAHMVA KAAPILRTQF FESPSQGHQL MQAVIDAPLE WTYSDKLDEY LMTDSTKIVQ
     LGQPTSRYAI ISNTQRYFVF TAHHAVYDGA SLGPMFEAVE KIYSENYVSS SSPYSLFVQY
     LLGMDSDSSK AYWEMSLQGA SAPTFPRLPS IGYRPMTNDA LKRTIALPAR HDTEFTMSSI
     ARAAWSLVVA SYSDTDDIVF ASTVGGRTLP IAGIENIIGP TLATVPVRVT IDRTASVSDF
     LTMIQEQSTS MMPHEQYGLQ NIKRISPSVS AASDLHNLLV INTSSVEGLG SGGLGLKQVD
     LGRADGFHNF ALSIECTAEA DALSLAVSFD DHVIDPRQIR RVVNQFEHML QQLSTCAIHT
     RLADMDLTGP ADIAEIHLWN SHVPPPQQNY VHTLVEQRVK SQPDSPAVCS WEGELTYREL
     DELSSSLANH LITAFAVAPG TLIPILFEKS IWTVVTMLAV LKAGGANVPM DPQQPLARLQ
     ELAADIGASL AISSSKYQDK AQNVTARSMF VDREVLTTIE KTPICPASTV SYEDPAFILF
     TSGSTGKPKA ILIDHTAFTS SIKGHGEILR YRKGSRNLQF TAYISDVSIG EIFTSLSAGA
     CVCVPSDFER MNDLAGSINR MRVDWAFLTP SVASLLDATK VPSLKTLVFG GETATPENIA
     AWAPRLFLIN SFGPAECSIW THCDPGVGIT HNGSHIGYAI GCATWIVDPN DYNKLAPIGS
     IGELIVEGPN VARGYLDEAK TKEAFLKTAA WMPSGRKNRL YKMGDLVRYL PDGKIQFLGR
     KDSQIKLHGQ RIELGEIEHQ LRVALAKHDA DRNVQVAVEM VSLSTDTSTS SLLTAFVDYE
     GISSDDGPAQ LSSGEKAQQW ARQMFRVAHE HLALTLPRHM IPSVLLPLTR MPLNGSAKTD
     RKVLKQIVSG MDTMQRALYS LARVETNIIK AATPNEKTLH HIWSEILSIS PESFGVEANF
     MSLGGDSIAA MKLIPIAQAA GLSISVEDLF TRPVLHDLAR VSRQSITEHS QDIPPFYIME
     QAQNQDELLA EASTHCNLPP DAIHDIYPCT QVQERFISTT QIQPGAYTLQ DVFKISSDMD
     LAQFKKAWTR TVASHVALRT RIFLSNDRHQ HLQVVQKASE TLDWIHSENL EEYLKADKAK
     SMEYGGSLVR SAIVSEGVER HFVVTYHHSI YDAVSLGIIM NDLEAFYLDD LYEVNEPKYN
     AFVHHLTQVK SQELSSQFWR DHLAGDRSTI TPLYQPVDGA RVDSLLRHTI TFPMHYQQSQ
     LSLTVAAFTY AALSLVTARL TGSSSAVLEL TLLGRSVPVK GIERMVGTTV TSAPLRIDTT
     AGNDKPWTVT VEDYLDYAKK RASSIVLHEH TSMPDPETKH ITSAALPIVV HPSNPHKEAL
     GTGIGLQRHE IQSMGQNSSA FYMDIAALDG EGLEINLPFD MPLDEVTRNV DHETDLRMCD
     IIEQEFRGYI ILALVNRLNF VPSCWTMGRW LNEAPRSTY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024